Induced EMT process |
Cells undergoing EMT acquire cancer stem cell (CSC) properties |
Enhances tumorigenesis |
[89,90,91,92,93,94] |
|
Snail1 protein reduces the glycogen synthase kinase-3 (GSK-3) activity |
Enhances carcinogenesis |
[95] |
YAP and TAZ |
Failure in maintaining the organ size, tissue homeostasis, cell proliferation, and stem cell properties |
Transformation of epithelial cells |
[97,98,99,100] |
Gastrokine 1 (GKN1) |
CagA-induced activation of ERK pathway and AUF1 upregulation decreases the expression of GKN1 |
Induces cell cycle progression and inhibits apoptosis, causing invasion and metastasis of the gastric cancer cell |
[103,104,105,106] |
Apoptosis-stimulating protein p53 2 |
In association with CagA, disrupts the cellular polarity, damaging the mucosal barrier |
Destroys the first-line defense mechanism causing survival of bacteria |
[109] |
Siva1 protein |
Causes the activation of the PI3K/Akt pathway and XIAP E3 ubiquitin ligase |
Tumorigenesis via the inhibition of apoptotic cell death, promoting the survival of damaged epithelial cells |
[110] |
Lrig1 |
Precise mechanism is unknown |
Promotes gastric carcinogenesis |
[111] |
Heat shock protein 1 (HSP1) |
CagA mediates downregulation of HSP1 |
Promotes persistent infection |
[113,114] |
Reg3 |
In association with CagA, alters the cell cycle, reducing its control on development |
Gastric carcinogenesis |
[115,116] |
Caudal type homeobox 1 (CDX1) |
CagA induces expression of CDX1, which promotes the cell proliferation and replacement of gastric epithelial cells with intestine-specific cells |
Gastric carcinogenesis and failure of common gastric cancer chemotherapies |
[117,118] |
CD44v9-positive cancer stem-like cells |
Protects the accumulated CagA after its translocation from autophagic degradation |
Causes the reprogramming and de-differentiation of the cells into cancer progenitor cells |
[95,126,127] |